Tridix Bio provides a comprehensive suite of assay services based on physiologically relevant 3D cellular models to support drug discovery and disease research. Our capabilities include viability and cytotoxicity assessments, proliferation and apoptosis assays, high-throughout drug screening with dose-response profiling, as well as in-depth analysis of gene and protein expression. We also offer cytokine profiling to evaluate inflammatory and immune responses. These assays are performed using organoid and spheroid systems that better reflect in vivo biology, enabling more predictive and translatbale results.